Rachael Gorman

The move to electronic medical records may be helping identity thieves.

A funding shift may encourage more fundamental brain research.

For patients to be effective partners in their own care requires a basic grasp of medical terms that, shockingly, many don’t have.

As resistance to antibiotics grows, might phages, a treatment that fell out of favor decades ago, be the answer?

Could natural killer cells, long thought to be blind and blunt, actually be discerning enough to help defeat HIV’s protean defenses?

Homeless patients suffer multiple afflictions that most doctors never see. Innovative programs are reaching and helping them.

Zinc fingers could pull gene therapy back from the brink—but only if more researchers can get their hands on the remarkable proteins.

The protein endothelin shows up everywhere, so scientists hoped blocking its action could treat many diseases. It hasn’t happened—yet.

An all-in-one medication reduced such cardiovascular risk factors as blood pressure and heart rate.

Synthetic biologists go far beyond genetic engineers, creating cellular computers, microbial drug factories and cancer-hunting bacteria.